These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10753224)

  • 21. Evidence for a recessive inheritance of Turcot's syndrome caused by compound heterozygous mutations within the PMS2 gene.
    De Rosa M; Fasano C; Panariello L; Scarano MI; Belli G; Iannelli A; Ciciliano F; Izzo P
    Oncogene; 2000 Mar; 19(13):1719-23. PubMed ID: 10763829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutagenesis in PMS2- and MSH2-deficient mice indicates differential protection from transversions and frameshifts.
    Andrew SE; Xu XS; Baross-Francis A; Narayanan L; Milhausen K; Liskay RM; Jirik FR; Glazer PM
    Carcinogenesis; 2000 Jul; 21(7):1291-5. PubMed ID: 10874005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differing patterns of genetic instability in mice deficient in the mismatch repair genes Pms2, Mlh1, Msh2, Msh3 and Msh6.
    Hegan DC; Narayanan L; Jirik FR; Edelmann W; Liskay RM; Glazer PM
    Carcinogenesis; 2006 Dec; 27(12):2402-8. PubMed ID: 16728433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequency and types of spontaneous Hprt lymphocyte mutations in Pms2-deficient mice.
    Shaddock JG; Dobrovolsky VN; Mittelstaedt RA; Heflich RH; Parsons BL
    Mutat Res; 2006 Mar; 595(1-2):69-79. PubMed ID: 16336979
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Levels of H-ras codon 61 CAA to AAA mutation: response to 4-ABP-treatment and Pms2-deficiency.
    Parsons BL; Delongchamp RR; Beland FA; Heflich RH
    Mutagenesis; 2006 Jan; 21(1):29-34. PubMed ID: 16314341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for the lack of mismatch-repair directed antirecombination during mouse meiosis.
    Qin J; Baker S; Te Riele H; Liskay RM; Arnheim N
    J Hered; 2002; 93(3):201-5. PubMed ID: 12195036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Truncation of the C-terminus of human MLH1 blocks intracellular stabilization of PMS2 and disrupts DNA mismatch repair.
    Mohd AB; Palama B; Nelson SE; Tomer G; Nguyen M; Huo X; Buermeyer AB
    DNA Repair (Amst); 2006 Mar; 5(3):347-61. PubMed ID: 16338176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of intragastric application of N-methylnitrosourea in p53 knockout mice.
    Ohgaki H; Fukuda M; Tohma Y; Huang H; Stoica G; Tatematsu M; Donehower LA
    Mol Carcinog; 2000 Jun; 28(2):97-101. PubMed ID: 10900466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pitfalls in molecular analysis for mismatch repair deficiency in a family with biallelic pms2 germline mutations.
    Leenen CH; Geurts-Giele WR; Dubbink HJ; Reddingius R; van den Ouweland AM; Tops CM; van de Klift HM; Kuipers EJ; van Leerdam ME; Dinjens WN; Wagner A
    Clin Genet; 2011 Dec; 80(6):558-65. PubMed ID: 21204794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA mismatch repair deficiency in breast carcinoma: a pilot study of triple-negative and non-triple-negative tumors.
    Wen YH; Brogi E; Zeng Z; Akram M; Catalano J; Paty PB; Norton L; Shia J
    Am J Surg Pathol; 2012 Nov; 36(11):1700-8. PubMed ID: 22992699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of heterozygosity and point mutation at Aprt locus in T cells and fibroblasts of Pms2-/- mice.
    Shao C; Yin M; Deng L; Stambrook PJ; Doetschman T; Tischfield JA
    Oncogene; 2002 Apr; 21(18):2840-5. PubMed ID: 11973643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Visualization of mosaicism in tissues of normal and mismatch-repair-deficient mice carrying a microsatellite-containing transgene.
    Hersh MN; Stambrook PJ; Stringer JR
    Mutat Res; 2002 Aug; 505(1-2):51-62. PubMed ID: 12175905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mice over-expressing human O6 alkylguanine-DNA alkyltransferase selectively reduce O6 methylguanine mediated carcinogenic mutations to threshold levels after N-methyl-N-nitrosourea.
    Allay E; Veigl M; Gerson SL
    Oncogene; 1999 Jun; 18(25):3783-7. PubMed ID: 10391687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mismatch repair gene PMS2: disease-causing germline mutations are frequent in patients whose tumors stain negative for PMS2 protein, but paralogous genes obscure mutation detection and interpretation.
    Nakagawa H; Lockman JC; Frankel WL; Hampel H; Steenblock K; Burgart LJ; Thibodeau SN; de la Chapelle A
    Cancer Res; 2004 Jul; 64(14):4721-7. PubMed ID: 15256438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparison of geno- and cytotoxicity of methylnitrosourea on MMR-proficient and MMR-deficient human tumor cell lines].
    Tronov VA; Kramarenko II; Smirnova TD; Terekhov SM
    Tsitologiia; 2006; 48(1):19-27. PubMed ID: 16568831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role for mismatch repair proteins Msh2, Mlh1, and Pms2 in immunoglobulin class switching shown by sequence analysis of recombination junctions.
    Schrader CE; Vardo J; Stavnezer J
    J Exp Med; 2002 Feb; 195(3):367-73. PubMed ID: 11828012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biallelic somatic inactivation of the mismatch repair gene MLH1 in a primary skin melanoma.
    Castiglia D; Pagani E; Alvino E; Vernole P; Marra G; Cannavò E; Jiricny J; Zambruno G; D'Atri S
    Genes Chromosomes Cancer; 2003 Jun; 37(2):165-75. PubMed ID: 12696065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circadian variation in the induction of intestinal tumors by N-methyl-N-nitrosourea in male C57BL/6N mice.
    Beland FA; Dooley KL; Sheldon WG; Delongchamp RR
    J Natl Cancer Inst; 1988 May; 80(5):325-30. PubMed ID: 3357199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid repair of O6-methylguanine-DNA adducts protects transgenic mice from N-methylnitrosourea-induced thymic lymphomas.
    Liu L; Allay E; Dumenco LL; Gerson SL
    Cancer Res; 1994 Sep; 54(17):4648-52. PubMed ID: 8062258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. N-Methyl-N-Nitrosourea (MNU): A positive control chemical for p53+/- mouse carcinogenicity studies.
    Morton D; Bailey KL; Stout CL; Weaver RJ; White KA; Lorenzen MJ; Ball DJ
    Toxicol Pathol; 2008 Dec; 36(7):926-31. PubMed ID: 18827072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.